These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21966820)
1. [Diagnosis of premature menopause measuring circulating anti-Müllerian hormone]. Zárate A; Hernández-Valencia M; Austria E; Saucedo R; Hernández M Ginecol Obstet Mex; 2011 May; 79(5):303-7. PubMed ID: 21966820 [TBL] [Abstract][Full Text] [Related]
2. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961 [TBL] [Abstract][Full Text] [Related]
3. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
4. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer]. Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496 [TBL] [Abstract][Full Text] [Related]
5. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964 [TBL] [Abstract][Full Text] [Related]
6. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?]. Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986 [TBL] [Abstract][Full Text] [Related]
7. The progressive reduction in the ovarian reserve in young women after anticancer treatment. Krawczuk-Rybak M; Leszczynska E; Poznanska M; Zelazowska-Rutkowska B; Wysocka J Horm Metab Res; 2013 Oct; 45(11):813-9. PubMed ID: 23950034 [TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Elgindy EA; El-Haieg DO; El-Sebaey A Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520 [TBL] [Abstract][Full Text] [Related]
9. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740 [TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811 [TBL] [Abstract][Full Text] [Related]
11. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation. Jayaprakasan K; Deb S; Batcha M; Hopkisson J; Johnson I; Campbell B; Raine-Fenning N Fertil Steril; 2010 Oct; 94(5):1775-81. PubMed ID: 19931077 [TBL] [Abstract][Full Text] [Related]
12. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles. Dehghani-Firouzabadi R; Tayebi N; Asgharnia M Arch Iran Med; 2008 Jul; 11(4):371-6. PubMed ID: 18588367 [TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Somunkiran A; Yavuz T; Yucel O; Ozdemir I Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955 [TBL] [Abstract][Full Text] [Related]
14. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome. Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139 [TBL] [Abstract][Full Text] [Related]
15. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition. Yang YS; Hur MH; Kim SY; Young K Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396 [TBL] [Abstract][Full Text] [Related]
16. Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles. Deb S; Campbell BK; Clewes JS; Pincott-Allen C; Raine-Fenning NJ Ultrasound Obstet Gynecol; 2013 Feb; 41(2):216-22. PubMed ID: 22744915 [TBL] [Abstract][Full Text] [Related]
17. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome. Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736 [TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311 [TBL] [Abstract][Full Text] [Related]
19. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556 [TBL] [Abstract][Full Text] [Related]
20. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]